TME PHARMA N.V.
Ownership & governance
Executives 5Directors 4Avg age 67Avg tenure 8.4y
DO
Diede van den Ouden
Chief Executive Officer
Since 2025-06-24Profile →
+8
Executives5
DO
Diede van den Ouden→
Chief Executive Officer
—Since 2025-06-24
JJ
Jarl Ulf Birger Jungnelius→
Chief Tech/Sci/R&D Officer
Age 75Since 2017-01-31
AM
Aram Andrew Mangasarian→
Chief Executive Officer
Age 56Since 2010-04-30
ES
Ewelina Staniuk→
Investor Relations Contact
—Since 2017-12-31
KO
Karen Ophoff→
Human Resources Officer
—Since 2000-12-31
Board of directors4
Shareholders2
| Name | Stake | Shares |
|---|---|---|
| Chart AG | 3.982 % | 3,750,964 |
| Gestys SA | 0.2123 % | 200,000 |
Catalog · 2026-07-09
Registry officers9
| Name | Role | Since | Shares |
|---|---|---|---|
| Aram Andrew Mangasarian | Chief Executive Officer | 2010-04-30 | - |
| Diede van den Ouden | Chief Executive Officer | 2025-06-24 | - |
| Jarl Ulf Birger Jungnelius | Chief Tech/Sci/R&D Officer | 2017-01-31 | - |
| Maurizio PetitBon | Chairman | 2019-06-24 | - |
| Diede van den Ouden | Director/Board Member | 2025-06-24 | - |
| Lee Schalop | Director/Board Member | 2024-06-26 | - |
| Susan Coles | Director/Board Member | 2021-06-23 | - |
| Ewelina Staniuk | Investor Relations Contact | 2017-12-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.